Neutralizing antibodies against feline parvoviruses in nondomestic felids inoculated with commercial inactivated polyvalent vaccines.
The virus neutralization (VN) antibody titers of serum samples from 18 individuals representing 8 carnivore species vaccinated with commercial polyvalent vaccines optimized for domestic cats containing inactivated feline panleukopenia virus (FPLV) were evaluated against canine parvovirus type 2 (CPV2). In addition, the titers among 5 individuals from 4 carnivore were evaluated against antigenic variants of feline parvoviruses; FPLV, CPV2, CPV2a, CPV2b, CPV2c, mink enteritis virus type 1 (MEV1) and MEV2. The polyvalent vaccines induced cross-reactive VN titers against antigenic variants of feline parvoviruses in nondomestic felids. However, we observed very low cross-reactive VN antibody in lions and Siberian tigers, therefore we should pay attention to CPV infections in these animals even if they were vaccinated with inactivated FPLV vaccines.
Sassa
Yukiko
Y
Laboratory of Veterinary Infectious Diseases, Department of Applied Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan.
Fukui
Daisuke
D
Takeshi
Kouichi
K
Miyazawa
Takayuki
T
D000818:Animals; D000836:Animals, Zoo; D000914:Antibodies, Viral / Q000097:blood*; D003429:Cross Reactions / Q000276:immunology; D045989:Felidae / Q000276:immunology*; D028301:Feline Panleukopenia Virus / Q000276:immunology*; D013045:Species Specificity; D014765:Viral Vaccines
D000914:Antibodies, Viral; D014765:Viral Vaccines